PMID- 11881998 OWN - NLM STAT- MEDLINE DCOM- 20020426 LR - 20190710 IS - 0022-2623 (Print) IS - 0022-2623 (Linking) VI - 45 IP - 6 DP - 2002 Mar 14 TI - First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease. PG - 1292-9 AB - Glycogen synthase kinase 3 beta (GSK-3beta) has a central role in Alzheimer's disease (AD). Selective inhibitors which avoid tau hyperphosphorylation may represent an effective therapeutical approach to the AD pharmacotherapy and other neurodegenerative disorders. Here, we describe the synthesis, biological evaluation, and SAR of the small heterocyclic thiadiazolidinones (TDZD) as the first non-ATP competitive inhibitor of GSK-3beta. Their synthesis is based on the reactivity of sulfenyl chlorides. In GSK-3beta assays, TDZD derivatives showed IC(50) values in the micromolar range, whereas in other protein kinases assays they were devoid of any inhibitory activity. SAR studies allowed the identification of the key structural features. Finally, a possible enzymatic binding mode is proposed. FAU - Martinez, Ana AU - Martinez A AD - Instituto de Quimica Medica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain. iqmam06@pinar2.csic.es FAU - Alonso, Mercedes AU - Alonso M FAU - Castro, Ana AU - Castro A FAU - Perez, Concepcion AU - Perez C FAU - Moreno, Francisco J AU - Moreno FJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Med Chem JT - Journal of medicinal chemistry JID - 9716531 RN - 0 (Enzyme Inhibitors) RN - 0 (Thiadiazoles) RN - 8L70Q75FXE (Adenosine Triphosphate) RN - EC 2.7.11.- (Glycogen Synthase Kinases) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinases) RN - EC 2.7.11.26 (Glycogen Synthase Kinase 3) SB - IM MH - Adenosine Triphosphate/metabolism MH - Alzheimer Disease/*drug therapy MH - Amino Acid Sequence MH - Animals MH - Binding, Competitive MH - Calcium-Calmodulin-Dependent Protein Kinases/*antagonists & inhibitors MH - Enzyme Inhibitors/*chemical synthesis/*pharmacology MH - Glycogen Synthase Kinase 3 MH - Glycogen Synthase Kinases MH - Humans MH - Molecular Sequence Data MH - Rabbits MH - Rats MH - Structure-Activity Relationship MH - Thiadiazoles/*chemical synthesis/*pharmacology EDAT- 2002/03/08 10:00 MHDA- 2002/04/27 10:01 CRDT- 2002/03/08 10:00 PHST- 2002/03/08 10:00 [pubmed] PHST- 2002/04/27 10:01 [medline] PHST- 2002/03/08 10:00 [entrez] AID - jm011020u [pii] AID - 10.1021/jm011020u [doi] PST - ppublish SO - J Med Chem. 2002 Mar 14;45(6):1292-9. doi: 10.1021/jm011020u.